95 investors have funded 29 Life Sciences companies head-officed in Amsterdam, across 145 rounds (Dec 2006 – Nov 2025). They are ranked by how many Amsterdam companies in this market they have actually backed.
"In Amsterdam" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | BioGeneration Ventures | Naarden, Netherlands | Series ASeedSeries B | 4 | 6 | 2 | Apr 2025 | 38 |
| 2 | Life Sciences Partners | Amsterdam, Netherlands | Post-IPOSeries ASeries B | 3 | 7 | — | Apr 2020 | 105 |
| 3 | BOM | Tilburg, Netherlands | Series ASeedSeries B | 3 | 4 | 2 | Apr 2025 | 104 |
| 4 | Innovatiefonds Noord-Holland | Amsterdam, Netherlands | Seed | 3 | 3 | 2 | Dec 2019 | 46 |
| 5 | F-Prime Capital | Cambridge, United States | Series ASeries B | 2 | 3 | 1 | Jun 2022 | 306 |
| 6 | Forbion | Naarden, Netherlands | Series BSeedSeries A | 2 | 3 | 3 | Dec 2024 | 108 |
| 7 | Inkef | Amsterdam, Netherlands | Series BSeries A | 2 | 3 | 2 | Mar 2022 | 50 |
| 8 | Life Sciences Fund Amsterdam | Amsterdam, Netherlands | Series ASeed | 2 | 3 | 1 | Mar 2014 | 4 |
| 9 | SoftBank Vision Fund | London, United Kingdom | Series DSeries B | 2 | 2 | — | Jan 2022 | 325 |
| 10 | EQT | Stockholm, Sweden | Series ASeed | 2 | 2 | 2 | Apr 2025 | 205 |
| 11 | Novartis Venture Fund | Basel, Switzerland | Series BSeries A | 2 | 2 | 1 | Dec 2024 | 139 |
| 12 | Lilly | Indianapolis, United States | Series ASeed | 2 | 2 | — | Jun 2021 | 110 |
| 13 | ROM InWest | Netherlands | SeedSeries A | 2 | 2 | — | Oct 2024 | 18 |
| 14 | Curie Capital | Amsterdam, Netherlands | Series ASeed | 2 | 2 | 1 | Apr 2025 | 8 |
| 15 | NLC | Amsterdam, Netherlands | Series ASeed | 2 | 2 | 1 | Sep 2025 | 9 |
| 16 | Demcon | Enschede, Netherlands | Series A | 2 | 2 | 2 | Aug 2022 | 9 |
| 17 | Nascent Ventures | Amsterdam, Netherlands | Series ASeed | 2 | 2 | 1 | Oct 2024 | 7 |
| 18 | Google Ventures | Mountain View, United States | Series ASeries B | 1 | 3 | 2 | Jan 2025 | 736 |
| 19 | Casdin Capital | New York City, United States | Series ASeries B | 1 | 3 | 1 | Jan 2025 | 136 |
| 20 | Balderton Capital | London, United Kingdom | Series ASeries B | 1 | 2 | 1 | Jan 2017 | 244 |
| 21 | Horizons Ventures | Hong Kong, China | SeedSeries A | 1 | 2 | — | Dec 2016 | 195 |
| 22 | Sofinnova Investments | Menlo Park, United States | Series ASeries B | 1 | 2 | 1 | Jan 2017 | 143 |
| 23 | Alta Partners | Jackson, United States | Series BSeries A | 1 | 2 | — | Nov 2012 | 118 |
| 24 | 360 Capital Partners | Paris, France | Series ASeries B | 1 | 2 | 1 | Oct 2009 | 114 |
| 25 | Oxford Science Enterprises | Oxford, United Kingdom | Series A | 1 | 2 | — | Mar 2022 | 85 |
| 26 | Hoxton Ventures | London, United Kingdom | Series ASeed | 1 | 2 | 1 | Jun 2022 | 62 |
| 27 | Draper Esprit | London, United Kingdom | Series BSeries A | 1 | 2 | — | Nov 2012 | 55 |
| 28 | Root Ventures | San Francisco, United States | SeedSeries A | 1 | 2 | — | Dec 2016 | 38 |
| 29 | Holland Capital | Amsterdam, Netherlands | Series A | 1 | 2 | 2 | Jun 2015 | 50 |
| 30 | Quest for Growth | Leuven, Belgium | Series BSeries A | 1 | 2 | — | Nov 2012 | 25 |
| 31 | NVNOM | Groningen, Netherlands | Series BSeries A | 1 | 2 | — | Nov 2012 | 19 |
| 32 | dRx Capital | Basel, Switzerland | SeedSeries A | 1 | 2 | — | Jun 2022 | 13 |
| 33 | Bessemer Venture Partners | Redwood City, United States | Series A | 1 | 1 | 1 | Jun 2022 | 781 |
| 34 | Insight Partners | New York City, United States | Series A | 1 | 1 | — | Nov 2023 | 762 |
| 35 | Polaris Partners | Boston, United States | Series B | 1 | 1 | 1 | Jan 2025 | 330 |
| 36 | Qiming Venture Partners | Shanghai, China | Series B | 1 | 1 | — | Jan 2025 | 337 |
| 37 | Octopus Ventures | London, United Kingdom | Series B | 1 | 1 | 1 | Jan 2017 | 300 |
| 38 | Global Brain | Shibuya, Japan | Series A | 1 | 1 | 1 | Dec 2016 | 292 |
| 39 | Earlybird | Berlin, Germany | Series B | 1 | 1 | 1 | Oct 2009 | 214 |
| 40 | HAX | San Francisco, United States | Seed | 1 | 1 | — | Sep 2017 | 283 |
| 41 | T. Rowe Price | Baltimore, United States | Series D | 1 | 1 | — | Apr 2021 | 214 |
| 42 | Sinovation Ventures | Beijing, China | Series A | 1 | 1 | — | Dec 2016 | 235 |
| 43 | SV Health Investors | Boston, United States | Series B | 1 | 1 | — | Aug 2009 | 154 |
| 44 | Seventure Partners | Paris, France | Series B | 1 | 1 | 1 | Jul 2020 | 175 |
| 45 | Invus | New York City, United States | Series B | 1 | 1 | — | Jan 2022 | 174 |
| 46 | Apax | Hong Kong, China | Series B | 1 | 1 | — | Aug 2009 | 148 |
| 47 | EQT Ventures | Stockholm, Sweden | Series B | 1 | 1 | 1 | Jan 2017 | 115 |
| 48 | Johnson & Johnson Innovation – JJDC | New Brunswick, United States | Series B | 1 | 1 | 1 | Dec 2024 | 120 |
| 49 | Founders Factory | London, United Kingdom | Seed | 1 | 1 | — | Jan 2021 | 164 |
| 50 | Gilde Healthcare | Cambridge, United States | Series D | 1 | 1 | — | Apr 2021 | 72 |
| 51 | Kurma Partners | Paris, France | Seed | 1 | 1 | — | Apr 2025 | 61 |
| 52 | Benhamou Global Ventures | Tel Aviv, Israel | Seed | 1 | 1 | — | Jun 2021 | 68 |
| 53 | Star Ventures | Herzliya, Israel | Series B | 1 | 1 | — | Aug 2009 | 62 |
| 54 | Bristol-Myers Squibb | New York City, United States | PE | 1 | 1 | — | Aug 2015 | 64 |
| 55 | BioMedPartners | Basel, Switzerland | Series A | 1 | 1 | — | Mar 2022 | 49 |
| 56 | Invest-NL | Amsterdam, Netherlands | Series A | 1 | 1 | 1 | Aug 2022 | 61 |
| 57 | Farallon Capital Management | San Francisco, United States | Series D | 1 | 1 | 1 | Apr 2021 | 59 |
| 58 | Kreos Capital | London, United Kingdom | Post-IPO | 1 | 1 | — | Oct 2020 | 56 |
| 59 | MVM | London, United Kingdom | Series A | 1 | 1 | — | Nov 2025 | 43 |
| 60 | Panorama Capital | Campbell, United States | Series B | 1 | 1 | — | Aug 2009 | 34 |
| 61 | MRLV | Cambridge, United States | Series A | 1 | 1 | — | Nov 2023 | 29 |
| 62 | FORWARD.one | Amstelveen, Netherlands | Series A | 1 | 1 | 1 | 28 | |
| 63 | Vesalius Biocapital Partners | Strassen, Luxembourg | Series A | 1 | 1 | — | Mar 2022 | 26 |
| 64 | V-Bio Ventures | Ghent, Belgium | Seed | 1 | 1 | — | Apr 2025 | 25 |
| 65 | Fortissimo Capital | Tel Aviv, Israel | Series B | 1 | 1 | 1 | Aug 2009 | 25 |
| 66 | Walden Catalyst | San Francisco, United States | Series A | 1 | 1 | — | Jun 2022 | 23 |
| 67 | Pura Vida Investments | New York City, United States | Series D | 1 | 1 | — | Apr 2021 | 23 |
| 68 | Pureos Bioventures | Pfaffikon, Switzerland | Series B | 1 | 1 | — | Dec 2024 | 19 |
| 69 | TechFund | Paris, France | Series A | 1 | 1 | — | Jan 2009 | 17 |
| 70 | Avego | Alpharetta, United States | Series C | 1 | 1 | — | Nov 2025 | 14 |
| 71 | Alafi Capital | San Francisco, United States | Series A | 1 | 1 | — | Nov 2009 | 12 |
| 72 | Irving Investors | New York City, United States | Series D | 1 | 1 | — | Apr 2021 | 16 |
| 73 | Rijksdienst voor Ondernemend Nederland | Haag, Germany | Seed | 1 | 1 | — | Nov 2017 | 13 |
| 74 | Clavystbio | Singapore | Series B | 1 | 1 | 1 | Jan 2025 | 12 |
| 75 | Eir Ventures | Stockholm, Sweden | Series A | 1 | 1 | 1 | Mar 2022 | 11 |
| 76 | SRI | Menlo Park, United States | Series A | 1 | 1 | — | Dec 2016 | 11 |
| 77 | Digital Science | London, United Kingdom | Series A | 1 | 1 | 1 | Jan 2017 | 12 |
| 78 | Achmea Innovation Fund | Amsterdam, Netherlands | Series A | 1 | 1 | 1 | Jun 2015 | 10 |
| 79 | Coller Capital | London, United Kingdom | PE | 1 | 1 | — | Jul 2013 | 10 |
| 80 | ALS Investment Fund | Amsterdam, Netherlands | Series A | 1 | 1 | — | Nov 2023 | 9 |
| 81 | Lauxera Capital Partners | Paris, France | Series D | 1 | 1 | 1 | Apr 2021 | 7 |
| 82 | Bluebird Ventures | Palo Alto, United States | Series B | 1 | 1 | — | Jan 2022 | 5 |
| 83 | Positron Ventures | Amsterdam, Netherlands | Seed | 1 | 1 | 1 | Jun 2022 | 7 |
| 84 | MSC | The Hague, Netherlands | Series A | 1 | 1 | — | Jun 2007 | 5 |
| 85 | Netspider Capital | Seed | 1 | 1 | — | Jun 2013 | 6 | |
| 86 | Byers Capital | Menlo Park, United States | Series B | 1 | 1 | — | Jan 2022 | 7 |
| 87 | TechNano Fund | Bilthoven, Netherlands | Seed | 1 | 1 | 1 | Nov 2017 | 4 |
| 88 | BrightGene | Suzhou, China | Series A | 1 | 1 | 1 | Jul 2019 | 3 |
| 89 | Parian Global Management | New York City | Series D | 1 | 1 | — | Apr 2021 | 3 |
| 90 | Healthliant Ventures | Seed | 1 | 1 | — | Sep 2025 | 3 | |
| 91 | UvA Ventures Holding | Amsterdam, Netherlands | Seed | 1 | 1 | 1 | Mar 2024 | 3 |
| 92 | TECHFUND | Shibuya, Japan | Series B | 1 | 1 | — | Oct 2009 | 1 |
| 93 | Modiquest | Oss, Netherlands | Series A | 1 | 1 | 1 | Jul 2019 | 1 |
| 94 | Brightgene | China | Series B | 1 | 1 | — | Jul 2020 | 1 |
| 95 | BGO Ventures | Seed | 1 | 1 | — | Sep 2025 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Amsterdam that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Citryll citryll.com |
11 | 12 | $510.1M | Series B Dec 2024 |
| Leyden Labs leydenlabs.com |
10 | 15 | $1.5B | Series B Jan 2025 |
| VectoryTx vectorytx.com |
8 | 10 | $978.2M | Series A Nov 2023 |
| LUMICKS lumicks.com |
8 | 8 | $747.1M | Series D Apr 2021 |
| Peptone peptone.io |
7 | 9 | $247.5M | Series A Jun 2022 |
| Kiadis Pharma kiadis.com |
7 | 13 | $196.2M | Post-IPO Oct 2020 |
| Avidicure avidicure.com |
6 | 6 | $300M | Seed Apr 2025 |
| Scenic Biotech scenicbiotech.com |
6 | 9 | $22M | Series A Mar 2022 |
| myTomorrows mytomorrows.com |
5 | 7 | $83M | Series C Nov 2025 |
| iTero itero.com |
5 | 5 | $75M | Series B Aug 2009 |
| Superflex superflextechnologies.com |
5 | 7 | $48M | Series A Dec 2016 |
| BMEYE bmeye.com |
5 | 8 | $35.3M | Series B Oct 2009 |
| Haermonics haermonics.com |
4 | 4 | $17.6M | Series A Aug 2022 |
| Amsterdam Scientific Instruments amscins.com |
4 | 4 | $9M | Seed Nov 2017 |
| SigmaScreening sigmascreening.com |
4 | 6 | — | Series A Jun 2015 |
| Confocal confocal.nl |
3 | 3 | $11.2M | Series A Oct 2024 |
| Ansana ansana.health |
3 | 3 | $5.3M | Seed Sep 2025 |
| UniQure uniqure.com |
2 | 2 | $111M | PE Aug 2015 |
| Kreatech kreatech.com |
2 | 2 | $6M | Series A Nov 2009 |
| Audion Therapeutics audiontherapeutics.com |
2 | 2 | $2.8M | Series B Sep 2015 |
| ELLOGON.AI ellogon.ai |
2 | 2 | $2.2M | Seed Mar 2024 |
| Avanzanite avanzanite.com |
1 | 1 | $37.1M | Series A Nov 2025 |
| CimCure cimcure.com |
1 | 1 | $5.3M | Seed Jun 2022 |
| Optics11 Life optics11life.com |
1 | 1 | $4M | |
| PacingCure pacingcure.com |
1 | 1 | $334.2K | Seed Dec 2019 |
| Digi.Bio digi.bio |
1 | 1 | $100K | Seed Sep 2017 |
| Peerwith peerwith.com |
1 | 1 | — | Series A Jan 2017 |
| Doctor Kinetic doctorkinetic.com |
1 | 1 | — | Seed Jun 2013 |
| Regenesance regenesance-pharma.com |
1 | 1 | — | Seed Dec 2010 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Nov 2025 | MVM | Avanzanite | Series A | $37.1M |
| Nov 2025 | Avego | myTomorrows | Series C | $29M |
| Sep 2025 | BGO Ventures | Ansana | Seed | $1.8M |
| Sep 2025 | Healthliant Ventures | Ansana | Seed | $1.8M |
| Sep 2025 | NLC | Ansana | Seed | $1.8M |
| Apr 2025 | V-Bio Ventures | Avidicure | Seed | $50M |
| Apr 2025 | BioGeneration Ventures | Avidicure | Seed | $50M |
| Apr 2025 | BOM | Avidicure | Seed | $50M |
| Apr 2025 | Kurma Partners | Avidicure | Seed | $50M |
| Apr 2025 | EQTLED | Avidicure | Seed | $50M |
| Apr 2025 | Curie Capital | Avidicure | Seed | $50M |
| Jan 2025 | Qiming Venture Partners | Leyden Labs | Series B | $70M |
| Jan 2025 | Google Ventures | Leyden Labs | Series B | $70M |
| Jan 2025 | Polaris PartnersLED | Leyden Labs | Series B | $70M |
| Jan 2025 | Casdin Capital | Leyden Labs | Series B | $70M |
| Jan 2025 | ClavystbioLED | Leyden Labs | Series B | $70M |
| Dec 2024 | Novartis Venture FundLED | Citryll | Series B | $89.8M |
| Dec 2024 | ForbionLED | Citryll | Series B | $89.8M |
| Dec 2024 | Johnson & Johnson Innovation – JJDCLED | Citryll | Series B | $89.8M |
| Dec 2024 | Pureos Bioventures | Citryll | Series B | $89.8M |
Life Sciences investors in other cities
Other markets in Amsterdam